The Minister of Labour announced the new amendments to the procedures that must be taken in the private sector to prevent and limit the spread of the Corona virus and transmit infection during the second wave of COVID-19, in the workplace to deal with epidemics and to protect workers and employers in the work environment To read the procedure please visit the link: http://www.mol.gov.jo/Default/Ar

A total of 252 new COVID-19 cases have been recorded in Jordan on Sunday, 248 of which are local cases, bringing the total number of cases since the beginning of the coronavirus crisis to 3,314. The increase in the number of cases is due to large gatherings, including weddings and funerals, and lack of compliance with health and safety measures. Two new COVID-19 deaths have been reported in Jordan on Sunday — in Prince Hamzah Hospital and Jordan University Hospital. A total of 50 recovery cases have been confirmed in Jordan on Sunday.

The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO. The benefit was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease. “This is the first treatment to be shown to reduce mortality in patients

Executive Summary C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight Covid-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica. The World Health Organization has announced the launch of the COVID-19 Technology Access Pool, or CTAP, insisting that the initiative “will help ensure faster and more equitable access to existing and new COVID-19 health products.” Last month, Costa Rican President Carlos Alvarado’s proposal on pooling rights to COVID-19 tests, medicines and vaccines, with free access or licensing on reasonable and affordable terms for all countries, was adopted

No new coronavirus cases were recorded in Jordan today, the Minister of Health, Saad Jaber, has announced. "However, one new death was reported at Queen Alia Military Hospital," Jaber said during a press briefing at the National Center for Security and Crisis Management. "Six recovery cases were reported today, bringing the total number of recovered cases to 351," the Minister stated. "Nearly 3,000 random COVID-19 tests have been conducted today and all the results were negative. We have increased our health capabilities, as we have so far produced 1,300,000 face masks. In addition, the number of epidemiological inspection teams have

Global health actors, private sector partners and other stakeholders are launching a landmark collaboration to accelerate the development, production and equitable global access to new COVID-19 essential health technologies. This event will be broadcast in English, with interpretation available in Arabic, Chinese, French, German, Spanish and Russian. To watch the event please watch: https://www.who.int/news-room/events/detail/2020/04/24/default-calendar/global-collaboration-to-accelerate-new-covid-19-tools

The heads of the World Customs Organization (WCO) and the World Trade Organization (WTO) issued a joint statement on 6 April pledging to work together to facilitate trade in essential goods such as medical supplies, food, and energy. WCO Secretary General Dr. Kunio Mikuriya and WTO Director-General Roberto Azevêdo said the two organizations would work closely together to minimize disruption to cross-border trade in goods – in particular those essential to combat the COVID-19 pandemic – while safeguarding public health. They also pledged to establish a coordinated approach to support initiatives that facilitate cross-border trade so that essential goods can

The International Generic and Biosimilar medicines Association (IGBA), which represents global manufacturers of generic and biosimilar medicines, today requests urgent action by all governments to designate all medicines as PRIORITY ESSENTIAL PRODUCTS, including all critical goods needed to manufacture them, so as to ensure that patients around the globe can continue to access the medicines they need during the COVID-19 pandemic. Given the surge in demand, in particular for Intensive Care Unit (ICU) medicines, there is an absolute urgency to facilitate and speed up the movement of essential products at all levels, in particular at customs control, as well as

Scientific brief No pharmaceutical products have yet been shown to be safe and effective for the treatment of COVID-19. However, a number of medicines have been suggested as potential investigational therapies, many of which are now being or will soon be studied in clinical trials, including the SOLIDARITY trial co-sponsored by WHO and participating countries. In many countries, doctors are giving COVID-19 patients medicines that have not been approved for this disease. The use of licensed medicines for indications that have not been approved by a national medicines regulatory authority is considered “off-label” use. The prescription of medicines for off-label

The International Generic and Biosimilar medicines Association (IGBA), which represents global manufacturers of generic and biosimilar medicines, today requested urgent action by governments and pharmaceutical supply chain stakeholders to reopen air freight routes and ensure patients around the globe can continue to have access to the medicines they need during the COVID-19 pandemic. “Air freight is a crucial part of the pharmaceutical supply chain. Pharmaceutical manufacturers rely on capacity in passenger flights to ship medicines and ingredients rapidly and securely,” said Hanan Sboul, IGBA Chair. “With the pandemic nature of the COVID-19 outbreak, there has been a dramatic reduction in